From: Characterizing and quantifying low-value diagnostic imaging internationally: a scoping review
Type of imaging | Reason for examination | Outcome | Suggested practice by included study/studies | References |
---|---|---|---|---|
Routine chest XR | Pre/post-operative Elective surgery | 0–4% change in management | XR is indicated pre-op for cancer, trauma, and cardiac patients | |
Post-op soft tissue sarcoma and stage I germ cell cancer | No change in management | Use chest CT instead | ||
Staging in breast or cervical cancer | 2.8% relevant findings | Â | ||
Medical check-up | 0.25% change in management | Â | [86] | |
At admission to hospital | Up to 4% relevant findings | Â | ||
Acute abdominal pain | 6% change in management | Â | [89] | |
Trauma patients | Marginal effect on management | Â | ||
Congenital lung malformations | No change in management | Â | [92] | |
Repeat chest XR | Trauma patients | 19% relevant findings | Use routine repeats only when initial chest XR is abnormal | [93] |
Routine follow-up chest XR | After thoracic invasive interventions |  < 1–5.6% change in management | XR patients with symptoms of pneumothorax only | [94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112] |
ICU patients | < 8% change in management | Image patients with positive physical examination only | [113] | |
Chest CT | Pleural effusion | 4% relevant findings | Â | [114] |
Emergency department patients | About 20% relevant findings | Â | [115] | |
Pre-op staging of breast cancer | 1.5% relevant findings | Useful for stage III patients only | [116] | |
Repeat chest CT | Covid-19 | No change in management when patient is clinically improving | Â | [117] |